TY - JOUR
T1 - Comparative proteomic profiling of plasma very-low-density and low-density lipoproteins
AU - Sun, Hung Yu
AU - Chen, Sun Fang
AU - Lai, Ming Derg
AU - Chang, Ting Tsung
AU - Chen, Tz Li
AU - Li, Pei Yu
AU - Shieh, Dar Bin
AU - Young, Kung Chia
N1 - Funding Information:
This study is supported by the National Science Council of Taiwan, R.O.C. under grants ( NSC 95-2320-B-006-021 and NSC 96-2320-B-006-005 ) and the Innovative and Exploratory project B035 from the National Cheng Kung University . The authors thank the Proteomics Research Core Laboratory of the National Cheng Kung University for their assistance in the preparation of 2-DE as well as Dr. Iain Bruce for his critical review of our manuscript.
PY - 2010/3/2
Y1 - 2010/3/2
N2 - Background: Low-density lipoprotein (LDL) is a natural metabolite of very-low-density lipoprotein (VLDL) in the circulation. Systematic investigation of total protein components and dynamics might provide insights into this normal metabolic process. Methods: VLDL and LDL were purified from normolipidemia pooled plasma by gradient ultracentrifugation with either ionic or non-ionic media. The protein contents were compared by liquid chromatography tandem mass analyses based on isobaric tag for relative and absolute quantitation and two-dimensional gel electrophoresis. Results: Our comparative lipoproteomes revealed 21 associated proteins. Combined with Western blot analysis, and on the basis of the differential expression levels we classified them into 3 groups: (i) VLDL > LDL [apolipoprotein (apo) A-IV, apo(a), apoCs, apoE, apoJ and serum amyloid A-4]; (ii) VLDL < LDL [albumin, α-1-antitrypsin, apoD, apoF, apoM, and paraoxonase-1]; and (iii) VLDL = LDL [apoA-I, apoA-II, apoB-100, apoL-I and prenylcysteine oxidase-1]. The apoA-I level positively correlated with PCYOX1 but negatively with apoM in VLDL and LDL. Furthermore, the two-dimensional maps displayed 5 apoA-I isoforms in which phosphorylation at Ser55, Ser166, Thr185, Thr221 and Ser252 residues were identified. Conclusions: This study revealed the VLDL- and LDL lipoproteomes and the full-spectrum protein changes during physiological VLDL-to-LDL transition. It provides a valuable dataset VLDL and LDL proteomes potentially applied to the development of diagnostics.
AB - Background: Low-density lipoprotein (LDL) is a natural metabolite of very-low-density lipoprotein (VLDL) in the circulation. Systematic investigation of total protein components and dynamics might provide insights into this normal metabolic process. Methods: VLDL and LDL were purified from normolipidemia pooled plasma by gradient ultracentrifugation with either ionic or non-ionic media. The protein contents were compared by liquid chromatography tandem mass analyses based on isobaric tag for relative and absolute quantitation and two-dimensional gel electrophoresis. Results: Our comparative lipoproteomes revealed 21 associated proteins. Combined with Western blot analysis, and on the basis of the differential expression levels we classified them into 3 groups: (i) VLDL > LDL [apolipoprotein (apo) A-IV, apo(a), apoCs, apoE, apoJ and serum amyloid A-4]; (ii) VLDL < LDL [albumin, α-1-antitrypsin, apoD, apoF, apoM, and paraoxonase-1]; and (iii) VLDL = LDL [apoA-I, apoA-II, apoB-100, apoL-I and prenylcysteine oxidase-1]. The apoA-I level positively correlated with PCYOX1 but negatively with apoM in VLDL and LDL. Furthermore, the two-dimensional maps displayed 5 apoA-I isoforms in which phosphorylation at Ser55, Ser166, Thr185, Thr221 and Ser252 residues were identified. Conclusions: This study revealed the VLDL- and LDL lipoproteomes and the full-spectrum protein changes during physiological VLDL-to-LDL transition. It provides a valuable dataset VLDL and LDL proteomes potentially applied to the development of diagnostics.
KW - Lipoproteome
KW - Low-density lipoprotein
KW - Quantitative proteomics
KW - Two-dimensional electrophoresis
KW - Very-low-density lipoprotein
KW - iTRAQ
UR - http://www.scopus.com/inward/record.url?scp=74849086822&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=74849086822&partnerID=8YFLogxK
U2 - 10.1016/j.cca.2009.11.023
DO - 10.1016/j.cca.2009.11.023
M3 - Article
C2 - 19945452
AN - SCOPUS:74849086822
SN - 0009-8981
VL - 411
SP - 336
EP - 344
JO - Clinica Chimica Acta
JF - Clinica Chimica Acta
IS - 5-6
ER -